{
    "clinical_study": {
        "@rank": "99212", 
        "arm_group": [
            {
                "arm_group_label": "Succinylcholine", 
                "arm_group_type": "Active Comparator", 
                "description": "Succinylcholine 0,5mg/kg as muscle relaxant during induction of anaesthesia for rigid bronchoscopy"
            }, 
            {
                "arm_group_label": "Rocuronium 0,3", 
                "arm_group_type": "Active Comparator", 
                "description": "Rocuronium 0,3 mg/kg during induction of anaesthesia for rigid bronchoscopy. At the end of procedure 2mg/kg sugammadex for reversal of neuromuscular block are applied."
            }, 
            {
                "arm_group_label": "Rocuronium 0,6", 
                "arm_group_type": "Active Comparator", 
                "description": "Rocuronium 0,6 mg/kg during induction of anaesthesia for rigid bronchoscopy. At the end of procedure 2mg/kg sugammadex for reversal of neuromuscular block are applied."
            }
        ], 
        "brief_summary": {
            "textblock": "Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as\n      rigid bronchoscopy. A more modern alternative is the application aof rocuronium, reversed by\n      sugammadex. The investigators compare the intubating conditions, incidence of postoperative\n      myalgia (POM) as well as patient satisfaction for these two muscle relaxants."
        }, 
        "brief_title": "Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy", 
        "condition": [
            "Intubating Conditions", 
            "Postoperative Myalgia", 
            "Patient Satisfaction"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age > 18 yr\n\n          -  scheduled for elective rigid bronchoscopy\n\n        Exclusion Criteria:\n\n          -  known neuromuscular disease\n\n          -  significant hepatic or renal dysfunction\n\n          -  family history of malignant hyperthermia\n\n          -  known allergy to one of the drugs used in this protocol\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01996358", 
            "org_study_id": "HSK004"
        }, 
        "intervention": [
            {
                "arm_group_label": "Succinylcholine", 
                "description": "Anaesthesia is induced and maintained with propofol  (1-2 mg/kg) and remifentanil (0,5 \u00b5g/kg). The study arm is immobilized and after cleaning the skin a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. After induction of anaesthesia the patient receives muscle relaxant according to the study group.", 
                "intervention_name": "Succinylcholine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Rocuronium 0,3", 
                "description": "General anaesthesia is induced and maintained with propofol (1-2mg/kg) and remifentanil (0,5\u00b5g/kg). The study arm is immobilized and after cleaning the skin a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. The Patient receives the muscle relaxant according to the study group.", 
                "intervention_name": "Rocuronium 0,3", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Rocuronium 0,6", 
                "description": "General anaesthesia is induced and maintained with propofol (1-2mg/kg) and remifentanil (0,5\u00b5g/kg). The study arm is immobilized and after cleaning the skin a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. The Patient receives the muscle relaxant according to the study group.", 
                "intervention_name": "Rocuronium 0,6", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Succinylcholine", 
                "Rocuronium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Succinylcholine", 
            "Rocuronium", 
            "Rigid Bronchoscopy"
        ], 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "contact": {
                "last_name": "Grietje Beck, Prof", 
                "phone": "0049 611 432176"
            }, 
            "facility": {
                "address": {
                    "city": "Wiesbaden", 
                    "country": "Germany", 
                    "state": "Hessen", 
                    "zip": "65199"
                }, 
                "name": "Dr. Horst Schmidt Klinik"
            }, 
            "investigator": {
                "last_name": "Verena Ghezel-Ahmadi, Dr", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparing Intubating Conditions Using Succinylcholine or Rocuronium/Sugammadex for Rigid Bronchoscopy: a Randomized Study", 
        "other_outcome": {
            "description": "measurement on a numeric ten point scale", 
            "measure": "Patient satisfaction", 
            "safety_issue": "No", 
            "time_frame": "72 hours after intervention"
        }, 
        "overall_contact": {
            "email": "grietje.beck@hsk-wiesbaden.de", 
            "last_name": "Grietje Beck, Prof", 
            "phone": "0049 611 432176"
        }, 
        "overall_contact_backup": {
            "email": "verena.ghezel-ahmadi@hsk-wiesbaden.de", 
            "last_name": "Verena Ghezel-Ahmadi, Dr", 
            "phone": "0049 611 432176"
        }, 
        "overall_official": {
            "affiliation": "Dr. Horst Schmidt Klinik", 
            "last_name": "Grietje Beck, Prof", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The intubating conditions will be measured using the scoring system proposed for Good Clinical Research Practice using the following variables: conditions of inserting the rigid bronchoscope, vocal cord position and coughing", 
            "measure": "Intubating Condition", 
            "safety_issue": "No", 
            "time_frame": "after induction of general anaesthesia (after 3-5 minutes)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01996358"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dr. Horst Schmidt Klinik GmbH", 
            "investigator_full_name": "Prof. Grietje Beck", 
            "investigator_title": "Professor Dr. med", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The severity of POM is measured by using a four-point-scale:\n0. no myalgia\nminor pain limited to one area of the body\nmuscle pain or stiffness noticed spontaneously by the patient, which may have required analgesic therapy\ngeneralized, severe or incapacitating discomfort", 
            "measure": "Postoperative Myalgia", 
            "safety_issue": "No", 
            "time_frame": "72 hours after intervention"
        }, 
        "source": "Dr. Horst Schmidt Klinik GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Horst Schmidt Klinik GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}